Vator Securities provides an extensive range of capital markets and advisory services to cutting-edge public and private growth companies with an emphasis on the Life Sciences, Medical Technology and Diagnostics sectors.
We apply an entrepreneurial spirit to everything we do. We build long lasting relationships with our clients based on mutual trust. Vator Securities executes on opportunities that accelerate growth for its client companies whilst delivering results to the firm’s sophisticated investor clientele.
Vator Securities is led by experienced professionals who have between 15 to 25 years of capital market and advisory experience from some of the world’s most prominent investment banks. Our service offering includes:
- Pre-IPO Financing
- IPOs and Secondaries
- Capital Markets Advisory
- Strategic Advisory
- Equity Research
Vator Securities distinguishes itself by the firm’s ability to raise capital from traditional institutional investors, as well as from its proprietary global network of family offices and high net worth investors. The unique network of investors implies that Vator Securities can source capital irrespective of financial market sentiments and create liquidity in the stock post IPO.
At Vator Securities every project is more than a single transaction. We specialize in providing partnerships where we work long-term with the client and support the value creation of a company long before a transaction commences. We focus on building a long-term strategy for our clients by guiding and consulting extensively throughout the entire life cycle – from idea to completion, but also through follow-ups and post transaction consulting and support.
200 MSEK | IPO | Q4 2018
Sole global coordinator and bookrunner
71 MSEK | Private placement | Q2 2018
40 MSEK | Private placement | Q2 2018
324 MSEK | Direct share issue | Q2 2018
50 MSEK | Private placement | Q2 2018
60 MSEK | Private placement | Q1 2018
80 MSEK | IPO | Q4 2017
334 MSEK | IPO | Q4 2017
90,1 MSEK | IPO | Q3 2017
100 MSEK | IPO | Q2 2017
70 MSEK | Private placement | Q2 2017
60 MSEK | IPO | Q1 2017
140,4 MSEK | IPO | Q4 2016
189,9 MSEK + 28,7 MSEK | Q3 2016
Private placement & rights issue
50 MSEK | Private placement | Q2 2016
100 MSEK | IPO Q4 | 2015
113,6 MSEK | Private placement | Q2 2015